|
1
|
Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, Grass G, Pregler M, Sing A, Hörmansdorfer S, Bernard H, Grunow R, Zimmermann R, Schneider-Brachert W, Gessner A, Reischl U. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill 2012; 17:20204. [PMID: 22790532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
Blood cultures from a heroin user who died in June 2012, a few hours after hospital admission, due to acute septic disease, revealed the presence of Bacillus anthracis. This report describes the extended diagnosis by MALDI-TOF and real-time PCR and rapid confirmation of the anthrax infection through reference laboratories. Physicians and diagnostic laboratories were informed and alerted efficiently through the reporting channels of German public health institutions, which is essential for the prevention of further cases.
Collapse
Affiliation(s)
- T Holzmann
- Institute of Medical Microbiology and Hygiene, University Hospital of Regensburg, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
2
|
Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, Grass G, Pregler M, Sing A, Hörmansdorfer S, Bernard H, Grunow R, Zimmermann R, Schneider-Brachert W, Gessner A, Reischl U. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill 2012. [DOI: 10.2807/ese.17.26.20204-en] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Blood cultures from a heroin user who died in June 2012, a few hours after hospital admission, due to acute septic disease, revealed the presence of Bacillus anthracis. This report describes the extended diagnosis by MALDI-TOF and real-time PCR and rapid confirmation of the anthrax infection through reference laboratories. Physicians and diagnostic laboratories were informed and alerted efficiently through the reporting channels of German public health institutions, which is essential for the prevention of further cases.
Collapse
Affiliation(s)
- T Holzmann
- Institute of Medical Microbiology and Hygiene, University Hospital of Regensburg, Regensburg, Germany
| | | | - M Simon
- Institute of Medical Microbiology and Hygiene, University Hospital of Regensburg, Regensburg, Germany
| | - P Noll
- Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
| | - S Schmoldt
- Bundeswehr Institute of Microbiology, Munich, Germany
| | - M Hanczaruk
- Bundeswehr Institute of Microbiology, Munich, Germany
| | - G Grass
- Bundeswehr Institute of Microbiology, Munich, Germany
| | - M Pregler
- District Health Office, Regensburg, Germany
| | - A Sing
- Bavarian Health and Food Safety Authority (LGL), Oberschleißheim, Germany
| | - S Hörmansdorfer
- Bavarian Health and Food Safety Authority (LGL), Oberschleißheim, Germany
| | - H Bernard
- Robert-Koch Institute, Berlin, Germany
| | - R Grunow
- Robert-Koch Institute, Berlin, Germany
| | | | - W Schneider-Brachert
- Institute of Medical Microbiology and Hygiene, University Hospital of Regensburg, Regensburg, Germany
| | - A Gessner
- Institute of Medical Microbiology and Hygiene, University Hospital of Regensburg, Regensburg, Germany
| | - U Reischl
- Institute of Medical Microbiology and Hygiene, University Hospital of Regensburg, Regensburg, Germany
| |
Collapse
|
|
3
|
Schmoldt S, Bruns CJ, Rentsch M, Siegert S, Nikolaou K, Hogardt M, Heesemann J, Tappe D. Skin fistulization associated with extensive alveolar echinococcosis. Ann Trop Med Parasitol 2010; 104:175-80. [PMID: 20406585 DOI: 10.1179/136485910x12607012374073] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- S Schmoldt
- Bundeswehr Institute of Microbiology, Munich, Germany
| | | | | | | | | | | | | | | |
Collapse
|
|
4
|
Sing A, Schmoldt S, Laubender R, Heesemann J, Sing D, Wildner M. Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors. Clin Microbiol Infect 2009; 15:957-60. [DOI: 10.1111/j.1469-0691.2009.02804.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
|
5
|
Balke B, Hogardt M, Schmoldt S, Hoy L, Weissbrodt H, Häussler S. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2007; 25:25-30. [PMID: 16402226 DOI: 10.1007/s10096-005-0076-9] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
The determination of synergistic effects of antimicrobial drug combinations can lead to improved therapeutic options in the antibiotic treatment of cystic fibrosis patients who are chronically infected with multiresistant Pseudomonas aeruginosa isolates. The aim of this study was to evaluate the performance of the E test versus the standard agar dilution checkerboard susceptibility test in the assessment of synergy and, in addition, to determine the activity of two antimicrobial combinations against 163 multiresistant P. aeruginosa isolates from cystic fibrosis patients. The agreement between the checkerboard method and the E test was excellent (>90%) for nonmucoid as well as mucoid isolates from cystic fibrosis patients. The rate of synergy was higher for the antibiotic combination of ceftazidime and tobramycin (28.8% of the cystic fibrosis strains) than for the combination of meropenem and tobramycin (19.0%). However, the probability of synergy for the second antibiotic combination increased significantly when the synergy of the first antibiotic combination had already been demonstrated (Fischer's exact test, p=0.049). The results show that the E test is a valuable and practical method for routine microbiological diagnostics and can aid in the selection of improved antibiotic options in the treatment of cystic fibrosis patients chronically infected with P. aeruginosa.
Collapse
Affiliation(s)
- B Balke
- Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hanover, Germany
| | | | | | | | | | | |
Collapse
|